Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotagliflozin in Young Adults with Type 1 Diabetes and Elevated A1C
NCT02383940Phase 2Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Apr 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 1 diabetes mellitus (T1D) comparing Placebo with Sotagliflozin (2 arms). Primary endpoint: Change From Baseline in Hemoglobin A1C at 12 weeks. Started Apr 2015; status: completed.
02
Drugs
sotagliflozin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02383940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02383940.